Inside Health Care

  • (Download)

With the Cure in Sight... A Doctor Who Honors His Oath - Seg. 1

Hagop M. Kantarjian, M.D., is a nonresident fellow in health policy. He serves as a professor and chair of the Department of Leukemia at The University of Texas MD Anderson Cancer Center, where he is also the Kelcie Margaret Kana Research Chair and associate vice president for global academic programs. As a clinical-translational researcher, Kantarjian has contributed to significant improvements in the treatment of various leukemias, including the development and testing of first- and second-generation BCR-ABL inhibitors in chronic myeloid leukemia, combination therapies for acute lymphocytic leukemia, and several new treatments for acute myeloid leukemia and myelodysplastic syndrome.

  • (Download)
  • (Download)
  • (Download)